Letter to Editor
The relationship between Statins and the risk of lung cancer
- Zabol University of Medical Sciences, Zabol, Iran
- Department of Social Medicine, School of Public Health, Dezful University of Medical Sciences, Dezful, Iran
- Student Research Committee, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran
- Department of Epidemiology and Biostatistics, School of Public Health, Shahrekord University of Medical Sciences, Shahrekord, Iran
- Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
Correspondence to:
Abdollah Mohammadian-Hafshejani,
Department of Epidemiology and Biostatistics, School of Public Health, Shahrekord University of Medical Sciences, Shahrekord, Iran; Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Email:
[email protected].
Published:
2018-05-15
Abstract
Lung cancer is the leading cause of death from cancer. There are annually around 1600000 of new cases and more than 1400000 deaths from this disease worldwide. Lung cancer accounted for 26% of death from cancer in females in the United States in 2012 and 29% of death from cancer in males. Statins are known as the most commonly prescribed drugs worldwide. Statins are usually used as the cholesterol-lowering drugs. The recent studies have proved the benefits of Statins in reducing the mortality and incidence of cardiovascular disease and stroke.